Molecular characterisation of breast cancer: the mutational landscape
Molecular characterisation of breast cancer: the mutational landscape
New cyclin-dependent kinase inhibitor with letrozole for ER+/HER2- breast cancer
Criteria required before implementation of whole genome arrays in clinical practice
Prognostic significance of progesterone receptor-positive tumour cells within luminal A breast cancer
Pregnancy following oestrogen receptor-positive breast cancer is safe
A pregnancy pill to prevent breast cancer?
Chemothereapy with endocrine therapy and bisphosphonates in early breast cancer
Endocrine management of breast cancer and advanced breast cancer
FLIMS workshop and management of triple negative breast cancer
Triple negative advanced breast cancer treatment with PARP inhibitors
Debate on the success of breast cancer screening programmes
Analysis of thirty years of clinical trial data